159 related articles for article (PubMed ID: 33142347)
1. Anticancer Potential of Compounds from the Brazilian Blue Amazon.
Wilke DV; Jimenez PC; Branco PC; Rezende-Teixeira P; Trindade-Silva AE; Bauermeister A; Lopes NP; Costa-Lotufo LV
Planta Med; 2021 Feb; 87(1-02):49-70. PubMed ID: 33142347
[TBL] [Abstract][Full Text] [Related]
2. Challenges and rewards of research in marine natural products chemistry in Brazil.
Berlinck RG; Hajdu E; da Rocha RM; de Oliveira JH; Hernández IL; Seleghim MH; Granato AC; de Almeida EV; Nuñez CV; Muricy G; Peixinho S; Pessoa C; Moraes MO; Cavalcanti BC; Nascimento GG; Thiemann O; Silva M; Souza AO; Silva CL; Minarini PR
J Nat Prod; 2004 Mar; 67(3):510-22. PubMed ID: 15043447
[TBL] [Abstract][Full Text] [Related]
3. Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products.
Valliappan K; Sun W; Li Z
Appl Microbiol Biotechnol; 2014 Sep; 98(17):7365-77. PubMed ID: 25064352
[TBL] [Abstract][Full Text] [Related]
4. The potential contribution of the natural products from Brazilian biodiversity to bioeconomy.
Valli M; Russo HM; Bolzani VS
An Acad Bras Cienc; 2018; 90(1 Suppl 1):763-778. PubMed ID: 29668803
[TBL] [Abstract][Full Text] [Related]
5. Current status on natural products with antitumor activity from Brazilian marine sponges.
Frota MJ; Silva RB; Mothes B; Henriques AT; Moreira JC
Curr Pharm Biotechnol; 2012 Jan; 13(1):235-44. PubMed ID: 21466432
[TBL] [Abstract][Full Text] [Related]
6. Novel Bioactive Natural Products Isolated from Madagascar Plants and Marine Organisms (2009-2017).
Dai Y; Liu Y; Rakotondraibe LH
Chem Pharm Bull (Tokyo); 2018; 66(5):469-482. PubMed ID: 29710044
[TBL] [Abstract][Full Text] [Related]
7. Drug development, Brazilian biodiversity and political choices: Where are we heading?
Ferreira PMP; Arcanjo DDR; Peron AP
J Toxicol Environ Health B Crit Rev; 2023 Jul; 26(5):257-274. PubMed ID: 36967535
[TBL] [Abstract][Full Text] [Related]
8. The impact of decreasing biodiversity on novel drug discovery: is there a serious cause for concern?
Newman DJ
Expert Opin Drug Discov; 2019 Jun; 14(6):521-525. PubMed ID: 30902034
[TBL] [Abstract][Full Text] [Related]
9. Natural Products: Perspectives and Challenges for use of Brazilian Plant Species in the Bioeconomy.
Valli M; Bolzani VS
An Acad Bras Cienc; 2019 Aug; 91(suppl 3):e20190208. PubMed ID: 31411242
[TBL] [Abstract][Full Text] [Related]
10. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives.
Dutra RC; Campos MM; Santos AR; Calixto JB
Pharmacol Res; 2016 Oct; 112():4-29. PubMed ID: 26812486
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and Biosynthetic Diversity in Marine Myxobacteria.
Gemperlein K; Zaburannyi N; Garcia R; La Clair JJ; Müller R
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30189599
[TBL] [Abstract][Full Text] [Related]
12. Marine Natural Products from New Caledonia--A Review.
Motuhi SE; Mehiri M; Payri CE; La Barre S; Bach S
Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26999165
[TBL] [Abstract][Full Text] [Related]
13. Marine Natural Products from Flora and Fauna of the Western Australian Coast: Taxonomy, Isolation and Biological Activity.
Sala S; Micke SK; Flematti GR
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771114
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Application of Diverse Marine-derived Natural Products in Cancer Therapy.
Yun CW; Kim HJ; Lee SH
Anticancer Res; 2019 Oct; 39(10):5261-5284. PubMed ID: 31570422
[TBL] [Abstract][Full Text] [Related]
15. Exploring marine resources for bioactive compounds.
Kiuru P; DʼAuria MV; Muller CD; Tammela P; Vuorela H; Yli-Kauhaluoma J
Planta Med; 2014 Sep; 80(14):1234-46. PubMed ID: 25203732
[TBL] [Abstract][Full Text] [Related]
16. Aquaculture expansion in Brazilian freshwaters against the Aichi Biodiversity Targets.
Lima Junior DP; Magalhães ALB; Pelicice FM; Vitule JRS; Azevedo-Santos VM; Orsi ML; Simberloff D; Agostinho AA
Ambio; 2018 May; 47(4):427-440. PubMed ID: 29306998
[TBL] [Abstract][Full Text] [Related]
17. Marine Natural Products from the Yucatan Peninsula.
Pech-Puch D; Pérez-Povedano M; Lenis-Rojas OA; Rodríguez J; Jiménez C
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31963310
[TBL] [Abstract][Full Text] [Related]
18. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.
Li T; Ding T; Li J
Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543
[TBL] [Abstract][Full Text] [Related]
19. Metabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology.
Barzkar N; Tamadoni Jahromi S; Poorsaheli HB; Vianello F
Mar Drugs; 2019 Aug; 17(8):. PubMed ID: 31398953
[TBL] [Abstract][Full Text] [Related]
20. Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012.
Hu Y; Chen J; Hu G; Yu J; Zhu X; Lin Y; Chen S; Yuan J
Mar Drugs; 2015 Jan; 13(1):202-21. PubMed ID: 25574736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
